MEDP|Analyst Targets
MEDP|Company Info
MEDP|Insider Trading
MEDP|Fundamentals
MEDP|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $4.93 | - | - |
| Q3'26 | $4.46 | $4.84 | +8.5% |
| Q2'26 | $4.00 | $4.25 | +6.2% |
| Q4'25 | $4.23 | $4.67 | +10.5% |
| Q4'24 | $3.12 | $3.68 | +18.1% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $733M | - | - |
| Q3'26 | $730M | $716M | -2.0% |
| Q2'26 | $701M | $707M | +0.8% |
| Q4'25 | $691M | $708M | +2.5% |
| Q4'24 | - | $537M | - |
MEDP|Monthly Returns
Market Data
MEDP Stock Snapshot
- Market cap
- 17.08B
- P/E ratio
- 33.0
- Day range
- $605.49 – $636.99
- News sentiment
- 58/100 · Neutral
- Analyst target
- $651.31 (+7.6%)
- Consensus
- Hold · 22 analysts
MEDP sits in the upper part of its 52-week range with the technical picture unresolved. Sector peers are worth watching - large caps in Healthcare tend to move together on rotation.
Behaviour On Record
What MEDP's own history says about today's numbers
- Realized volatility (21d)
- 35.5% 50th pct
- Below its peak
- -11.9%
- vs 200-day average
- +14.5%
- Up days (1y)
- 52%
Medpace Holdings, Inc. is currently running 35.5% annualised volatility over the last 21 sessions. Measured against MEDP's own 10 years of daily returns rather than a market-wide average, that is the 50th percentile — close to its own typical level, against a typical reading of 35.5%.
MEDP is trading -11.9% below its running peak. Across 10 full years on file, its median worst-drawdown-in-a-year was -32.1%, and the deepest was -40.8% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits +14.5% from its 200-day moving average. Against every other day in its history, that gap ranks at the 50th percentile — close to the gap it normally carries. Over the past year MEDP closed higher on 52% of sessions, and it is currently 3 sessions into a falling streak.
On November specifically: over 11 years of records, MEDP finished the month higher 6 of 11 times, with a median return of +2.2% and an average of +3.3%. Its strongest month historically has been July at +13.7% on average, its weakest February at -4.8%.
Overnight risk is measurable too: MEDP has opened more than 2% away from the prior close in 132 of 2,584 sessions (5.1% of the time), with the largest gaps running +24.0% and -15.8%.
Across the last 3 dated reports on file, MEDP moved an average of 5.5% in the session after earnings, closing higher 0 of those 3 times, with a median move of -2.9% and a largest of -11.6%.
All figures computed from 2,585 daily closes between 2016-08-11 and 2026-11-20, split-adjusted, recomputed daily. Percentiles are against MEDP's own 10-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of MEDP's sector?
Medpace Holdings, Inc. sits in the Industrials sector, currently ranked 8th of 12 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #8 of 12
- Sector state
- Leading
- Sector rotation score
- 36
Analyst Rating Changes
Are analysts turning bullish or bearish on MEDP?
BMO Capital most recently reiterated its rating on Medpace Holdings, Inc. to Market Perform on Oct 26, 2026 with a price target of $670 (from $600). Over the last 90 days, coverage has run 1 upgrade against 0 downgrades, a net bullish lean.
- Latest action
- BMO Capital: Market Perform
- 90-day upgrades
- 1
- 90-day downgrades
- 0
- Net rating momentum
- +1
Earnings Release, Scored
What did Medpace Holdings, Inc.'s latest earnings release say?
Most important lines
- 1
Backlog as of September 30, 2026 increased 5.6% to $3,167.2 million from $3,000.6 million as of September 30, 2025.
- 2
On a constant currency basis, EBITDA for the third quarter of 2026 increased 16.0% from the third quarter of 2025.
- 3
On a constant currency basis, revenue for the third quarter of 2026 increased 8.6% compared to the third quarter of 2025.
Peers & ETF holders
MEDP peers & ETF holders
Diagnostics & ResearchMarket cap · today
News & sentiment
What is the news saying about MEDP?
MEDP fell 1.9% over the month to Nov 20. News tone held between 21 and 75 from Oct 20 to Oct 28, then jumped to 89 on Oct 29.
- Oct 21 +4.9%same day: Medpace Holdings, Inc. Reports Third Quarter 2026 Results
- Oct 23 +4.4%same day: Medpace: 3 Key Takeaways for Long-Term Investors
- Oct 30 -3.8%same day: Medpace (MEDP) is a Great Momentum Stock: Should You Buy?
Technical analysis
How strong is MEDP's momentum right now?
On the daily chart MEDP ranks at the 50th percentile for momentum against 1,063 stocks and ETFs, a neutral reading.
Institutional ownership
Are big funds buying or selling MEDP?
85 of the 172 tracked managers added to MEDP in their latest 13F and 78 trimmed. Together they own 57.7% of the company, worth $10.1B. BlackRock and AQR Capital Management alone hold 14.0%.
- 1BlackRock, Inc.9.09%$1.6B positionAdded 2.6% last quarter
- $863.2M positionAdded 9.2% last quarter
- $677.4M positionTrimmed 4.2% last quarter
- $627.9M positionTrimmed 2.0% last quarter
- 5State Street Corp2.53%$445.9M positionAdded 0.5% last quarter
- $444.7M positionAdded 0.3% last quarter
- 7Invesco Ltd.1.78%$313.1M positionTrimmed 13.4% last quarter
- $312.0M positionAdded 16.5% last quarter
- $282.4M positionAdded 8.9% last quarter
- 10Baillie Gifford & Co1.60%$282.0M positionTrimmed 4.5% last quarter
Congressional trading
Is Congress trading MEDP?
4 members of Congress disclosed 10 MEDP trades between Jan 13, 2025 and May 15, 2026: 4 buys and 6 sells, about $104.5K in estimated value.
What stands out
Click one to highlight its trades in the chartDiscover more
How has MEDP done against its peers?
Over the six months to Nov 20, MEDP returned +44.7%. Of the 15 related stocks and ETFs, 5 did better, led by CRL at +101.4%.
- 1CRLCharles River Laboratories International, Inc.up 101.4%+56.7 pts
- 2MTDMettler-Toledo International Inc.up 54.0%+9.2 pts
- 3RVTYRevvity, Inc.up 53.2%+8.5 pts
- 4AAgilent Technologies, Inc.up 50.3%+5.6 pts
- 5TMOThermo Fisher Scientific Inc.up 48.2%+3.5 pts
- 6MEDPThis stockup 44.7%
- 7IQVIQVIA Holdings Inc.up 43.3%−1.4 pts
- 8LHLabcorp Holdings Inc.up 42.6%−2.1 pts
- 16XLVHealth Care Select Sector SPDR Fundup 20.5%−24.3 pts